tirzepatide vs ozempic for weight loss caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Mounjaro vs. Ozempic: Effectiveness, Side

A separate 2024 analysis in Frontiers in Endocrinology showed that 0.5 mg weekly led to sustained weight loss and metabolic improvements over 12 months in patients with type 2 diabetes

Jastreboff AM, Ryan DH, Bays HE, Ebeling PR, Mackowski MG, Philipose N, et al

Rolls ET, Grabenhorst F

EFSA 2003

Because AOD-9604 does not activate growth hormone receptors and functions through an entirely separate beta-3 adrenergic pathway, it does not trigger cortisol release

Weight loss can prevent patients from developing serious health concerns, such as: High blood pressure Heart disease Diabetes Cancer When you achieve your weight loss results with semaglutide, you can live a healthier life every day